ECS Expands into Germany Through National Distribution Partnership

ECS Botanics (ASX: ECS) has secured a distribution partnership that provides access to Germany, Europe’s largest medicinal cannabis market. The agreement provides access to nationwide pharmacy distribution and positions ECS to launch its OzSun product range using its existing EU-GMP-certified production capacity. Initial sales are targeted for April 2026, with premium ECS-grown genetics planned for later release. The expansion supports ECS’s international growth strategy while maintaining a capital-efficient, value-focused market approach.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au